(Hypertension. 1996;27:72-78.)
© 1996 American Heart Association, Inc.
Articles |
From the Department of Medicine, Division of Nephrology and Hypertension, Northwestern University Medical School, and Lakeside Veterans Administration Medical Center, Chicago, Ill.
Correspondence to Daniel Batlle, MD, Northwestern University Medical School, Division of Nephrology and Hypertension, 325 E Superior, Searle 10-475, Chicago, IL 60611.
Abstract The aim of the present study was to define the
effects of angiotensin II (Ang II) and Ang-(1-7) on free
cytosolic Na+ (Na+i), intracellular
pH (pHi), and the Na+-H+ antiporter
in cultured vascular smooth muscle cells from rat aorta. Cells were
loaded with either BCECF-AM or SBFI-AM for measurement of
pHi and Na+i, respectively.
Ang II (10-6 mol/L) caused a rapid rise in
Na+i followed by a progressive increase that
peaked at about 10 minutes (from 11±1.5 to 16±1.5 mmol/L,
P<.001), whereas Ang-(1-7) (10-6 mol/L) did
not affect Na+i significantly (from 11.5±1.1
to 11.8±0.07 mmol/L). The effect of Ang II on
Na+i was concentration dependent
(
Na+i, 5.1±0.9, 3.8±0.6,
1.6±0.6,
and 0.14±0.18 mmol/L with decreasing concentrations of
10-6, 10-7,
10-8, and 10-9 mol/L, respectively).
Ang II caused a brief acidification followed by an increase in
pHi (from 7.34±0.03 to 7.43±0.03 after 10 minutes,
P<.005), and Ang-(1-7) had no significant effect on
pHi (from 7.23±0.03 to 7.23±0.03). To investigate
whether
pHi and Na+i changes induced by Ang
II were due to cell Na+ entry via stimulation of the
Na+-H+ antiporter, we pretreated cells with
EIPA (25 µmol/L) or ouabain (2.0 mmol/L). Ang II in the presence of
ouabain caused a greater increase than that seen with ouabain alone
(
Na+i, 13±1.5 versus 6.3±1.2
mmol/L, P<.0025). EIPA by itself decreased
Na+i and pHi. After EIPA, Ang II
failed to increase both Na+i and
pHi, demonstrating that the
Na+-H+ antiporter is responsible for the rises
in Na+i and pHi during stimulation
with Ang II. To further characterize the mechanism of Ang II action, we
exposed cells to an Ang II type 1 receptor antagonist
(L-158,809, 10-6 mol/L) or two different type 2 receptor
antagonists (PD 123177 and CGP 421112A, 10-6
mol/L). L-158,809 completely blocked the rise in pHi caused
by Ang II, whereas PD 123177 and CGP 421112A did not. We conclude that
Ang II increases both Na+i and
pHi, and both effects are mediated by stimulation of
the Na+-H+ antiporter. Ang-(1-7), by contrast,
has no significant effect on Na+i,
pHi, or the Na+-H+
antiporter. Stimulation of this antiporter by Ang II is exerted through
the type 1 receptor.
Key Words: muscle, smooth, vascular angiotensins sodium/hydrogen antiporter
This article has been cited by other articles:
![]() |
S. Sasaki, H. M. Siragy, J. J. Gildea, R. A. Felder, and R. M. Carey Production and Role of Extracellular Guanosine Cyclic 3', 5' Monophosphate in Sodium Uptake in Human Proximal Tubule Cells Hypertension, February 1, 2004; 43(2): 286 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pieske and S. R Houser [Na+]i handling in the failing human heart Cardiovasc Res, March 15, 2003; 57(4): 874 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wu and C. H. Fry Na+/Ca2+ exchange and its role in intracellular Ca2+ regulation in guinea pig detrusor smooth muscle Am J Physiol Cell Physiol, May 1, 2001; 280(5): C1090 - C1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz and E. L. Schiffrin Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chen, Y. V. Mukhin, M. N. Garnovskaya, T. E. Thielen, Y. Iijima, C. Huang, J. R. Raymond, M. E. Ullian, and R. V. Paul A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation Am J Physiol Renal Physiol, September 1, 2000; 279(3): F440 - F448. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ueda, S. Masumori-Maemoto, K. Ashino, T. Nagahara, E. Gotoh, S. Umemura, and M. Ishii Angiotensin-(1-7) Attenuates Vasoconstriction Evoked by Angiotensin II but Not by Noradrenaline in Man Hypertension, April 1, 2000; 35(4): 998 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gunasegaram, R. S. Haworth, D. J. Hearse, and M. Avkiran Regulation of Sarcolemmal Na+/H+ Exchanger Activity by Angiotensin II in Adult Rat Ventricular Myocytes : Opposing Actions via AT1 Versus AT2 Receptors Circ. Res., November 12, 1999; 85(10): 919 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakamura, Y. Ohya, I. Abe, and M. Fujishima Sodium-potassium pump current in smooth muscle cells from mesenteric resistance arteries of the guinea-pig J. Physiol., August 15, 1999; 519(1): 203 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wunsch, C. P. Sanchez, M. Gekle, L. Grosse-Wortmann, J. Wiesner, and M. Lanzer Differential Stimulation of the Na+/H+ Exchanger Determines Chloroquine Uptake in Plasmodium falciparum J. Cell Biol., January 26, 1998; 140(2): 335 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Iyer, C. M. Ferrario, and M. C. Chappell Angiotensin-(1-7) Contributes to the Antihypertensive Effects of Blockade of the Renin-Angiotensin System Hypertension, January 1, 1998; 31(1): 356 - 361. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |